US Patent Issued to SHENZHEN READLINE BIOTECH on Sept. 15 for "Mutant enzyme, use thereof and process for preparing tripeptide by using enzymatic method" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,735,694, issued on Sept. 15, was assigned to SHENZHEN READLINE BIOTECH Co. LTD. (Shenzhen, China).

"Mutant enzyme, use thereof and process for preparing tripeptide by using enzymatic method" was invented by Tiemei Yu (Shenzhen, China), Junfeng Pan (Shenzhen, China) and Jian Liu (Shenzhen, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to the technical field of biochemistry. Disclosed are a mutant enzyme, the use thereof and a process for preparing a tripeptide by using an enzymatic method. The mutant enzyme comprises: glycine and L-histidine ligase GHS, and tripeptide ligase HKS; or a fusion enzyme of the two. Glycin...